Medical technology company Stryker Corp. has lodged two appeals in an attempt to reverse patent board rulings that invalidated its patents for a surgical implant. The initial rulings came after numerous patents claims were challenged by Berkshire Hathaway-owned rival, OsteoMed. The disputed patents are also central to a related legal case in an Illinois federal court.
The appeals represent the latest development in what is becoming an increasingly complex legal dispute over patent rights within the field of surgical implants. While details of the federal court case remain ambiguous, it is clear that the result of these appeals could set a significant precedent.
The patent board’s initial decision and the subsequent appeals come amidst a background of heightened legal activity in the medical technology field. This case underscores the particular sensitivity around patent rights and the significant implications these can have on businesses within the sector.
For more in-depth information on Stryker’s recent moves, please visit Law360 .